OliLux Biosciences — Rapid Tuberculosis Detection and Treatment Management Tools

[Human Health and Wellbeing] Grant investigators: Heather Youngs and Chris Somerville This page was reviewed but not written by the grant investigators. OliLux Biosciences staff also reviewed this page prior to publication. Open Philanthropy recommended an investment of $400,000 in OliLux Biosciences to support the development of diagnostic and treatment monitoring tools for the detection and management of tuberculosis. The tools rapidly distinguish between active and inactive tuberculosis pathogens, have lower detection limits than existing detection methods, will be accessible in low-resource settings, and are expected to be useful in identification of drug resistance and sensitivity. This falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.